| Literature DB >> 34541460 |
Leesa Lin1,2, Yi Song3, Qian Wang3, Jialu Pu3, Fiona Yueqian Sun1, Yixuan Zhang3, Xinyu Zhou3, Heidi J Larson1, Zhiyuan Hou3,4,5.
Abstract
BACKGROUND: Massive community-wide testing has become the cornerstone of management strategies for the COVID-19 pandemic.Entities:
Keywords: COVID-19; China; United Kingdom; public response; sentiment; social listening; test
Year: 2021 PMID: 34541460 PMCID: PMC8404307 DOI: 10.2196/26895
Source DB: PubMed Journal: JMIR Infodemiology ISSN: 2564-1891
Figure 1Numbers of daily new COVID-19 cases in the United Kingdom (UK), London, mainland China, and Beijing from June 1 to July 15, 2020 [26,27].
Figure 2Percentage of tweets or Weibo posts with attitudes toward individual COVID-19 tests and community-wide tests from June 1 to July 15, 2020. UK: United Kingdom.
Figure 3Percentage of tweets or Weibo posts with attitudes toward COVID-19 testing by week and daily new cases from June 1 to July 15, 2020. UK: United Kingdom.
Figure 4Percentage of tweets/Weibo posts with oppositional attitude toward COVID-19 testing and number of cases by geographical distribution in the United Kingdom (UK) and mainland China from June 1 to July 15, 2020 (regions with less than 50 tweets/posts are not shown).
Uptake of COVID-19 tests in the United Kingdom and mainland China.
| Uptake and driving forces | United Kingdom (N=3856), n (%) | London (N=794), n (%) | China (N=9299), n (%) | Beijing (N=3155), n (%) | |||||
|
| 178 (4.6) | 39 (4.9) | 3318 (35.7) | 1462 (46.3) | |||||
|
| Plan to take a test | 35 (0.9) | 7 (0.9) | 811 (8.7) | 417 (13.2) | ||||
|
| Have taken a test | 143 (3.7) | 32 (4.0) | 2507 (27.0) | 1045 (33.1) | ||||
|
| 86 (2.2) | 25 (3.2) | 1600 (17.2) | 824 (26.1) | |||||
|
| Personal health needs | 37 (1.0) | 14 (1.8) | 163 (1.8) | 64 (2.0) | ||||
|
| Mandatory testing policies for travel | 30 (0.8) | 9 (1.1) | 659 (7.1) | 223 (7.1) | ||||
|
| Community-wide testing by governments | 19 (0.5) | 2 (0.3) | 784 (8.4) | 543 (17.2) | ||||
| Others taking COVID-19 tests | 86 (2.2) | 16 (2.0) | 277 (3.0) | 102 (3.2) | |||||
Convenience of COVID-19 tests in the United Kingdom and mainland China.
| Convenience of COVID-19 tests | United Kingdom (N=3856), n (%) | London (N=794), n (%) | China (N=9299), n (%) | Beijing (N=3155), n (%) | |||||
|
| 43 (1.1) | 8 (1.0) | 753 (8.1) | 221 (7.0) | |||||
|
| Feel uncomfortable | 30 (0.8) | 5 (0.6) | 476 (5.1) | 118 (3.7) | ||||
|
| Feel nervous | 7 (0.2) | 2 (0.3) | 234 (2.5) | 70 (2.2) | ||||
|
| Do not feel uncomfortable | 6 (0.2) | 1 (0.1) | 111 (1.2) | 43 (1.4) | ||||
|
| 356 (9.2) | 132 (16.6) | 2005 (21.6) | 754 (23.9) | |||||
|
| Access to an appointment | 25 (0.6) | 8 (1.0) | 93 (1.0) | 52 (1.6) | ||||
|
| Wait time to take a test | 53 (1.4) | 19 (2.4) | 1579 (17.0) | 557 (17.7) | ||||
|
| Wait time for the test result | 82 (2.1) | 10 (1.3) | 174 (1.9) | 114 (3.6) | ||||
|
| Others | 211 (5.5) | 99 (12.5) | 186 (2.0) | 48 (1.5) | ||||
| Tribute to medical staff | 69 (1.8) | 15 (1.9) | 1914 (20.6) | 480 (15.2) | |||||
| Price of COVID-19 testing | 96 (2.5) | 53 (6.7) | 598 (6.4) | 196 (6.2) | |||||
| Priority groups for COVID-19 testing | 665 (17.2) | 9 (1.1) | 271 (2.9) | 101 (3.2) | |||||
Confidence and complacency toward COVID-19 tests in the United Kingdom and mainland China.
| Confidence and complacency | United Kingdom (N=3856), n (%) | London (N=794), n (%) | China (N=9299), n (%) | Beijing (N=3155), n (%) | ||||||
|
|
|
|
|
| ||||||
|
|
| 164 (4.3) | 49 (6.2) | 417 (4.5) | 164 (5.2) | |||||
|
|
| Trust tests to be effective | 34 (0.9) | 16 (2.0) | 275 (3.0) | 102 (3.2) | ||||
|
|
| Doubt the effectiveness of tests | 130 (3.4) | 33 (4.2) | 142 (1.5) | 62 (2.0) | ||||
|
| Expiration date of COVID-19 tests | 1 (0.03) | 0 (0) | 87 (0.9) | 42 (1.3) | |||||
|
| Incidental risks due to COVID-19 tests | 14 (0.4) | 3 (0.4) | 206 (2.2) | 113 (3.6) | |||||
|
|
|
|
|
| ||||||
|
|
| 152 (3.9) | 45 (5.7) | 813 (8.7) | 299 (9.5) | |||||
|
|
| High risk | 139 (3.6) | 44 (5.5) | 789 (8.5) | 286 (9.1) | ||||
|
|
| Low risk | 13 (0.3) | 1 (0.1) | 24 (0.3) | 13 (0.4) | ||||
Communication around COVID-19 tests in the United Kingdom and mainland China.
| Communication around COVID-19 tests | United Kingdom (N=3856), n (%) | London (N=794), n (%) | China (N=9299), n (%) | Beijing (N=3155), n (%) |
| Information inquiries about COVID-19 tests | 75 (1.9) | 21 (2.6) | 517 (5.6) | 137 (4.3) |
| Rumors about COVID-19 tests | 55 (1.4) | 12 (1.5) | 192 (2.1) | 27 (0.9) |
Attitude toward COVID-19 tests by characteristics for Chinese Weibo posts.
| Characteristic | Attitude toward individual COVID-19 tests | Attitude toward community-wide COVID-19 tests | ||||||||||||||||||||
|
| Total | Dominant, n (%) | Negotiated, n (%) | Oppositional, n (%) |
| Total | Dominant, n (%) | Oppositional, n (%) |
| |||||||||||||
|
|
|
|
|
| <.001 |
|
|
| <.001 | |||||||||||||
|
| Male | 2844 | 989 (34.8) | 1587 (55.8) | 268 (9.4) |
| 660 | 614 (93.0) | 46 (7.0) |
| ||||||||||||
|
| Female | 5940 | 1626 (27.4) | 3814 (64.2) | 500 (8.4) |
| 910 | 882 (96.9) | 28 (3.1) |
| ||||||||||||
|
| Total | 8784 | 2615 (29.8) | 5401 (61.5) | 768 (8.7) |
| 1570 | 1496 (95.3) | 74 (4.7) |
| ||||||||||||
|
|
|
|
|
| <.001 |
|
|
| .05 | |||||||||||||
|
| 10-30 | 2705 | 680 (25.1) | 1793 (66.3) | 232 (8.6) |
| 356 | 344 (96.6) | 12 (3.4) |
| ||||||||||||
|
| 30-90 | 1125 | 420 (37.3) | 602 (53.5) | 103 (9.2) |
| 269 | 251 (93.3) | 18 (6.7) |
| ||||||||||||
|
| Total | 3830 | 1100 (28.7) | 2395 (62.5) | 335 (8.7) |
| 625 | 595 (95.2) | 30 (4.8) |
| ||||||||||||
|
|
|
|
|
| .49 |
|
|
| .90 | |||||||||||||
|
| Bachelor’s degree or above | 2297 | 704 (30.6) | 1387 (60.4) | 206 (9.0) |
| 472 | 450 (95.3) | 22 (4.7) |
| ||||||||||||
|
| High school or below | 6582 | 1945 (29.6) | 4067 (61.8) | 570 (8.7) |
| 1122 | 1068 (95.2) | 54 (4.8) |
| ||||||||||||
|
| Total | 8879 | 2649 (29.8) | 5454 (61.4) | 776 (8.7) |
| 1594 | 1518 (95.2) | 76 (4.8) |
| ||||||||||||
Uptake of COVID-19 tests by characteristics for Chinese Weibo posts.
| Characteristic | Uptake of COVID-19 tests | Driving force for taking a COVID-19 test | ||||||||||||||||||
|
| Total | Yes, n (%) | No, n (%) |
| Total | Personal health needs, n (%) | Mandatory testing policies for travel, n (%) | Community-wide tests, n (%) |
| |||||||||||
|
|
|
|
| <.001 |
|
|
|
| .44 | |||||||||||
|
| Male | 2844 | 808 (28.4) | 2036 (71.6) |
| 413 | 37 (9.0) | 167 (40.4) | 209 (50.6) |
| ||||||||||
|
| Female | 5940 | 2470 (41.6) | 3470 (58.4) |
| 1170 | 126 (10.8) | 487 (41.6) | 557 (47.6) |
| ||||||||||
|
| Total | 8784 | 3278 (37.3) | 5506 (62.7) |
| 1583 | 163 (10.3) | 654 (41.3) | 766 (48.4) |
| ||||||||||
|
|
|
|
| <.001 |
|
|
|
| .09 | |||||||||||
|
| 10-30 | 2705 | 1187 (43.9) | 1518 (56.1) |
| 506 | 60 (11.9) | 229 (45.3) | 217 (42.9) |
| ||||||||||
|
| 30-90 | 1125 | 316 (28.1) | 809 (71.9) |
| 193 | 22 (11.4) | 71 (36.8) | 100 (51.8) |
| ||||||||||
|
| Total | 3830 | 1503 (39.2) | 2327 (60.8) |
| 699 | 82 (11.7) | 300 (42.9) | 317 (45.4) |
| ||||||||||
|
|
|
|
| .001 |
|
|
|
| .16 | |||||||||||
|
| Bachelor’s degree or above | 2297 | 922 (40.1) | 1375 (59.9) |
| 444 | 45 (10.1) | 166 (37.4) | 233 (52.5) |
| ||||||||||
|
| High school or below | 6582 | 2395 (36.4) | 4187 (63.6) |
| 1162 | 118 (10.2) | 493 (42.4) | 551 (47.4) |
| ||||||||||
|
| Total | 8879 | 3317 (37.4) | 5562 (62.6) |
| 1606 | 163 (10.1) | 659 (41.0) | 784 (48.8) |
| ||||||||||